MYC and colorectal carcinoma: Although the late-stage CRC cells (HCT116 and DLD-1) we used for establishing these mouse models express higher c-Myc protein levels than those that represent the early stage, we tried to further increase the c-Myc expression in these cells and examined whether it would affect the potency of dihydroartemisinin in CRC.